Form D · Biotechnology
Alafair Biosciences, Inc.
Austin, TX · CIK 0001539007
Offering snapshot reported Oct 23, 2018 · SEC filing
- Reported sold
- $2.33M Offering amount: $6.83M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 28, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2018 | Initial | $2,330,168 | No comparison | 15 | SEC filing |
| Jul 19, 2017 | Initial | $965,000 | No comparison | 9 | SEC filing |
| Oct 28, 2015 | Initial | $984,040 | No comparison | 11 | SEC filing |
| May 15, 2014 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Sep 11, 2013 | Initial | $525,000 | No comparison | 3 | SEC filing |
| Jan 9, 2012 | Initial | $702,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-324080
The Total Offering Amount and Total Amount Sold include an aggregate amount of $1,830,168 from convertible notes (reported on the Issuer's Form D filed 7-19-2017) that automatically converted into equity of the Issuer.
Source: Form D, filed Oct 23, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Benedyk | Director |
| R. Gregory Brophy | Executive |
| Kyle A. Cox | Director |
| Jerry De Vries | Director |
| James Patrick Feller | Director |
| Jim Gamett | Director |
| John B. Henneman | Director |
| John B. Henneman, Iii | Director |
| John Joyoprayitno | Executive |
| Christophe Lavigne | Director |
| Daniel Peterson | Director |
| Robert P. Wills | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6101 W. Courtyard Drive Suite 2 225
Austin, TX, 78730
Austin, TX, 78730